Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Lung Cancer Screening Clinical Trial

Official title:

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02914899
• Other study ID #: 16-949
• Status: Active, not recruiting
• Phase: Early Phase 1
• Start date: August 2016
• Est. completion date: May 2024

Study information

• Verified date: January 2024
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to test if our Community Health Worker program can help at-risk NYC Chinese community members participate in shared decision making and lung cancer screening (if appropriate) and compare it to the help provided by written materials.

Description:

The study first used qualitative methods to inform the adaptation of a CHW model to facilitate lung cancer screening completion in an extremely high-risk group, NYC Chinese livery drivers who smoke or who quit within the past 15 years. A series of focus groups with Chinese livery drivers who smoke, a series of in-depth interviews with livery base management and staff, primary care physicians (PCPs), clinic directors, hospital CFOs, heads of financial services and counseling, and heads of radiology facilities serving the Chinese community were conducted to explore barriers and factors related to cancer screening. Findings were used to develop adapted intervention materials, including a CHW Manual for Facilitating Shared Decision Making and Lung Cancer Screening. Once adaptation is complete, the researchers will conduct a pre-pilot to refine the adapted CHW intervention materials. The researchers will then conduct a pilot randomized controlled trial (RCT) to assess the feasibility of the refined CHW model (intervention) versus written materials (control) to facilitate SDM and LCS (when appropriate) in an extremely high-risk group, NYC Chinese livery drivers eligible (by USPTSF criteria) for LCS. Feasibility results will be used to inform the planning and design of large scale RCTs, targeting Chinese drivers, as well as other driver populations in NYC and throughout the U.S., and other high risk Chinese smoking populations in other occupations (e.g. restaurant work, construction). The study is currently in the pre-pilot phase and expects to launch the pilot phase by the summer of 2020. Due to the effects of the COVID-19 crisis, the researchers have extended the pre-pilot participation time frame to 12 months. The study population has also indicated concern to attend doctor's appointments for SDM/LCS during COVID-19. As such, MSK is extending the study time frame to an additional 6 months. . CHWs will also be hosting health education workshops at community organizations, family associations, and public libraries. These workshops will be conducted in English, Mandarin, and Cantonese and cover topics including smoking cessation and lung cancer screening.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 99
• Est. completion date: May 2024
• Est. primary completion date: May 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 80 Years

Eligibility

Inclusion Criteria:

Focus Group Participants:

• Of Chinese descent
• Non-U.S. born
• Fluent in Mandarin
• Livery driver
• Age 45-80
• Current or past (within 15 years) cigarette smoker (no specific pack year requirement) In Depth Interview Participants Livery Staff
• Of Chinese descent
• Non-U.S. born
• Fluent in Mandarin
• Livery base owner or employee
• Age = 21

Health Care Providers and Administrators:

• Primary care physician, clinic director, hospital administrator, or radiology facility or department administrator
• Age = 21
• Fluent in English

CHW pre-pilot RCT participants:

• Of Chinese descent
• Fluent in Mandarin
• Male
• Livery driver
• Age 55-80 years old
• Driven for 3 months or longer
• 30 pack year history
• Current smoker or quit within 15 years
• Will not be traveling out of New York Area for more than 1 month in the next 3 months CHW pilot RCT participants
• Of Chinese descent
• Fluent in Mandarin or Cantonese
• Male
• Professional driver
• Age 50-80 years old
• Driven for 3 months or longer
• Last drove professionally within the last 18 months with plans of returning
• 20 pack year smoking history
• Current smoker or quit within 15 years
• Will not be traveling out of New York Area for more than 3 months in the next 12 months
• Has not completed LDCT in the past year.

Exclusion Criteria:

• Has a household member who has already participated (or agreed to participate).

Related Conditions & MeSH terms

• Current or Past Cigarette Smoker
• Lung Cancer Screening
• Lung Neoplasms

Intervention

Behavioral:
• Surveys
Intake surveys recorded demographics, workplace profile, financial profile, health care access, cancer screening behavior, medical history, etc. Exit surveys asked whether drivers received shared decision making (SDM) counseling, completed LCS (low-dose computed tomography [LDCT] scan), had barriers, felt satisfied, etc.
• Navigation
CHWs facilitated SDM and LCS for drivers, providing navigation ( finding a PCP, scheduling appointments, assisting with insurance, etc.), following up on results and next steps.
• Focus groups
Gained drivers' perspectives on adapting the community health worker (CHW) model to facilitate lung cancer screening (LCS).
• In-depth interviews
Interviews with Chinese livery bases elicited perspectives on adapting the CWH model for the drivers' occupational environment. Interviews with PCPs, clinic directors, etc. serving Chinese communities provided insight into adapting the CHW model within the health care context.

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering Cancer Center	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	(Pre-Pilot Phase) Increased uptake in SDM and LCS	To determine whether participation in the interventions leads to increased completion of SDM and LCS with LDCT.	2 years
Primary	(Pilot Phase) Increased uptake in SDM and LCS	To determine whether participation in the interventions leads to increased completion of SDM and LCS with LDCT.	2 years

External Links

•   Memorial Sloan Kettering Cancer Center